NCT03700164

Brief Summary

The purpose of the study is to evaluate the effect of cold exposure on an individual's glucose tolerance. Previous research has already shown that 10 days acclimation to a mild cold environment (14-15°C) can enhance insulin sensitivity. However, the duration in the cold environment was 6 hours per day which may not be practical for everyone. Therefore, the present study will investigate the effect of a shorter, and more intense cold exposure on an individual's glucose tolerance. It is hypothesised that cold exposure before consuming a glucose drink will enhance glucose clearance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2018

Completed
28 days until next milestone

First Posted

Study publicly available on registry

October 9, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

January 11, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

July 14, 2020

Status Verified

July 1, 2020

Enrollment Period

10 months

First QC Date

September 11, 2018

Last Update Submit

July 13, 2020

Conditions

Keywords

Cold ExposureGlucose Tolerance

Outcome Measures

Primary Outcomes (1)

  • Glucose and insulin concentrations in response to an oral glucose load

    3 hours post glucose drink, measured 90 minutes after the cold exposure

Secondary Outcomes (9)

  • Energy expenditure measured using indirect calorimetry

    30 minutes before and during the 1 hour of cold exposure

  • Core temperature measured using a telemetric pill

    30 minutes before and during the 1 hour of cold exposure

  • Skin blood flow measured using laser doppler flowmetry

    30 minutes before and during the 1 hour of cold exposure

  • Shivering activity assessed using surface electromyography

    30 minutes before and during the 1 hour of cold exposure

  • Systolic and diastolic blood pressure measured using an automatic blood pressure device

    30 minutes before and during the 1 hour of cold exposure

  • +4 more secondary outcomes

Study Arms (2)

Cold exposure

EXPERIMENTAL

Participants will be wrapped in a water-perfused suit. The temperature of the suit will be lowered to 10°C. From the onset of shivering, the participants will remain in the suit for 1 hour.

Other: Temperature

Thermoneutral (Control)

OTHER

Participants will be wrapped in a water-perfused suit. The temperature of the suit will remain at a thermoneutral temperature (32°C) to avoid shivering and excessive sweating. The duration will be matched to that during the cold exposure.

Other: Temperature

Interventions

Water-perfused suit.

Cold exposureThermoneutral (Control)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed informed consent.
  • White European.
  • Male.
  • Age 18 - 40 years at the start of the study.
  • BMI ≥ 20 and \< 30 kg/m2.

You may not qualify if:

  • Smoking.
  • Active diseases (cardiovascular, diabetes mellitus, liver, kidney, cancer or other).
  • Cold-acclimated (takes daily cold baths, works in a refrigerated environment, or regular cold water swimmer).
  • Unstable body weight (gain or loss \> 5kg in last 3 months).
  • Currently undertaking a diet.
  • Signed informed consent.
  • White European.
  • Male or female.
  • Women should be postmenopausal or use hormonal contraceptives.
  • Age 30 - 75 years at the start of the study.
  • BMI ≥ 25 and \< 35 kg/m2.
  • Generally healthy, no medication use that interferes with metabolism. If volunteers need medication (e.g. statin drugs, NSAIDs), it will be reviewed with the dependent physician on an individual basis.
  • Impaired fasting glucose (5.6 mM to 6.9 mM) and/or blood glucose values 7.8-11.0 mM 2h after glucose drink consumption during OGTT in screening.
  • Smoking.
  • Active diseases (cardiovascular, diabetes mellitus, liver, kidney, cancer or other).
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University

Maastricht, 6229 ER, Netherlands

Location

MeSH Terms

Conditions

Hyperglycemia

Interventions

Temperature

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

ThermodynamicsPhysical PhenomenaWeatherAtmosphereEnvironmentEcological and Environmental PhenomenaBiological PhenomenaMeteorological ConceptsEnvironment, ControlledEnvironment and Public Health

Study Officials

  • Wouter van Marken Lichtenbelt, PhD

    Maastricht University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: It is anticipated that 32 participants will enrol in the study. Specifically, 16 participants will be healthy individuals and the other 16 will be individuals with impaired fasting glucose (5.6 mM to 6.9 mM) and/or blood glucose values 7.8-11.0 mM 2h after glucose drink consumption during the OGTT in screening. Initially, the study will investigate the effect of the cold exposure on healthy individuals, and then depending on the results in these individuals, the intervention may be tested on participants with impaired glucose metabolism.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2018

First Posted

October 9, 2018

Study Start

January 11, 2019

Primary Completion

November 1, 2019

Study Completion

November 1, 2019

Last Updated

July 14, 2020

Record last verified: 2020-07

Locations